Richard D. Francis, President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 149,060 shares at $13.15 ($2.0M) on 2024-02-15, disclosed to the SEC on 2024-02-20.
Scheduled sale ($2.0M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.15 | 74,530 | $980K | 50.0% |
| 2 | $13.15 | 74,530 | $980K | 50.0% |
| Total | $13.15 avg | 149,060 | $2.0M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $1.5M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $28.7M | — | Filing → |
| TEVA | SELL | 2026-02-18 | $30.6M | — | Filing → |